Definium Therapeutics
The Associate Director, Medical Marketing supports the development and execution of strategic medical marketing initiatives to drive the successful commercial launch of DT120. This role involves leading KOL engagement, managing advisory boards and congress activities, and partnering with cross-functional teams to align scientific engagement with corporate goals. The position requires ensuring all activities meet regulatory and compliance standards while shaping the scientific engagement strategy.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
Associate Director, Scientific Marketing - Ophthalmology
Regeneron Pharmaceuticals
Associate Medical Director, US Rare Hematology
AstraZeneca
Senior Director, KOL and Advocacy Engagement
Apogee Therapeutics
Marketing - Sjogren's Disease Launch, Senior Manager
Sentral
Marketing - Sjogren's Disease Launch, Senior Manager
Sentral
Staff Medical & Scientific Affairs Liaison – Cardiometabolic
Leica Biosystems